Literature DB >> 25160541

Central nervous system manifestations in pediatric patients with influenza A H1N1 infection during the 2009 pandemic.

Ashley N Wilking1, Elizabeth Elliott2, Melissa N Garcia3, Kristy O Murray3, Flor M Munoz4.   

Abstract

BACKGROUND: A novel H1N1 influenza A virus (A(H1N1)pdm09) particularly affected individuals <24 years of age during the 2009 pandemic. This study sought to better understand the risks and outcomes of central nervous system complications associated with pandemic influenza in the pediatric population.
METHODS: Retrospective review of patients with laboratory-confirmed influenza A(H1N1)pdm09 infection and central nervous system manifestations at Texas Children's Hospital between April 2009 and June 2010.
RESULTS: Among 365 patients with influenza A(H1N1)pdm09, 32 (8.8%) had central nervous system manifestations at a median age of 4 years. Eight (25.0%) were previously healthy, and 12 (37.5%) had neurological pre-existing conditions. Of the 32 cases of influenza with neurological complications, seizure (n = 17; 53.1%) was the most common central nervous system manifestation, followed by encephalitis (n = 4; 12.5%), meningitis (n = 4; 12.5%), encephalopathy (n = 3; 9.4%), meningismus (n = 3; 9.4%), focal hemorrhagic brain lesions (n = 2; 6.3%), brain infarction (n = 1; 3.1%), and sensorineural hearing loss (n = 1; 3.1%). Two patients demonstrated two or more types of central nervous system complications. One patient had abnormal cerebrospinal fluid with pleocytosis. Almost two thirds of the children with central nervous system manifestations required intensive care unit admission and nearly half required mechanical ventilation. There were no deaths.
CONCLUSIONS: Patients with pre-existing neurological conditions were at greater risk for central nervous system manifestations during pandemic influenza infection. Patients with central nervous system manifestations were more likely to experience severe illness, characterized by intensive care unit admission and mechanical ventilation, although overall outcomes were good. Influenza prevention in patients with underlying medical conditions, particularly those with neurological conditions, is important.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  central nervous system; influenza; neurological disorders; novel H1N1; vaccination

Mesh:

Year:  2014        PMID: 25160541     DOI: 10.1016/j.pediatrneurol.2014.04.026

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  15 in total

1.  Localization Analysis of Heterophilic Antigen Epitopes of H1N1 Influenza Virus Hemagglutinin.

Authors:  Chun-Yan Guo; Hai-Xiang Zhang; Jun-Jun Zhang; Li-Jun Sun; Hui-Jin Li; Dao-Yan Liang; Qing Feng; Yan Li; Yang-Meng Feng; Xin Xie; Jun Hu
Journal:  Virol Sin       Date:  2019-04-24       Impact factor: 4.327

2.  Neurologic Manifestations of Influenza A(H3N2) Infection in Children During the 2016-2017 Season.

Authors:  Suchitra Rao; Jan Martin; M Alex Ahearn; Christina Osborne; Angela Moss; Amanda Dempsey; Samuel R Dominguez; Adriana Weinberg; Kevin B Messacar
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

3.  Neuroinfluenza: evaluation of seasonal influenza associated severe neurological complications in children (a multicenter study).

Authors:  Muhammet Sukru Paksu; Kerim Aslan; Tanil Kendirli; Basak Nur Akyildiz; Nazik Yener; Riza Dincer Yildizdas; Mehmet Davutoglu; Ayhan Yaman; Sedat Isikay; Gulnar Sensoy; Haydar Ali Tasdemir
Journal:  Childs Nerv Syst       Date:  2017-07-31       Impact factor: 1.475

4.  Severe post-influenza (H1N1) encephalitis involving pulvinar nuclei in an adult patient.

Authors:  José Tomás; Maria Carmo Macário; Elsa Gaspar; Isabel Santana
Journal:  BMJ Case Rep       Date:  2015-10-22

Review 5.  Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy.

Authors:  Marta C Nunes; Shabir A Madhi
Journal:  F1000Res       Date:  2018-01-29

6.  Neonatal influenza virus infection affects myelination in influenza-recovered mouse brain.

Authors:  Jin Hee Kim; Ji Eun Yu; Byung-Joon Chang; Sang-Soep Nahm
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

7.  CSF neopterin, a useful biomarker in children presenting with influenza associated encephalopathy?

Authors:  Emma Macdonald-Laurs; Archana Koirala; Philip N Britton; William Rawlinson; Chee Chung Hiew; Jocelynne Mcrae; Russell C Dale; Cheryl Jones; Kristine Macartney; Brendan McMullan; Sekhar Pillai
Journal:  Eur J Paediatr Neurol       Date:  2018-09-28       Impact factor: 3.140

8.  Clinical predictors of disease severity during the 2009-2010 A(HIN1) influenza virus pandemic in a paediatric population.

Authors:  M N Garcia; D C Philpott; K O Murray; A Ontiveros; P A Revell; L Chandramohan; F M Munoz
Journal:  Epidemiol Infect       Date:  2015-02-02       Impact factor: 4.434

9.  Neurological Manifestations of Influenza A (H1N1): Clinical Features, Intensive Care Needs, and Outcome.

Authors:  Lalit Takia; Lokesh Saini; Shivan Keshavan; Suresh Kumar Angurana; Karthi Nallasamy; Renu Suthar; Sanjay Verma; Paramjeet Singh; Kapil Goyal; R K Ratho; Muralidharan Jayashree
Journal:  Indian J Pediatr       Date:  2020-05-02       Impact factor: 1.967

10.  Mouse-adapted H9N2 avian influenza virus causes systemic infection in mice.

Authors:  Zhe Hu; Yiran Zhang; Zhen Wang; Jingjing Wang; Qi Tong; Mingyang Wang; Honglei Sun; Juan Pu; Changqing Liu; Jinhua Liu; Yipeng Sun
Journal:  Virol J       Date:  2019-11-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.